LATEST MN 553 Week 5 Quiz: Pharmacology LATEST UPDATES A+ GUARANTEE

Elderly patients who are started on levothyroxine for thyroid replacement should be monitored for: (Points : 1) Excessive sedation Tachycardia and angina Weight gain Cold intolerance Question 2.2. Potentially fatal granulocytopenia has been associated with treatment of hyperthyroidism with propylthiouracil. Patients should be taught to report: (Points : 1) Tinnitus and decreased salivation Fever and sore throat Hypocalcemia and osteoporosis Laryngeal edema and difficulty swallowing Question 3.3. Metformin is a primary choice of drug to treat hyperglycemia in type 2 diabetes because it: (Points : 1) Substitutes for insulin usually secreted by the pancreas Decreases glycogenolysis by the liver Increases the release of insulin from beta cells Decreases peripheral glucose utilization Question 4.4. Hypoglycemia can result from the action of either insulin or an oral hypoglycemic. Signs and symptoms of hypoglycemia include: (Points : 1) “Fruity” breath odor and rapid respiration Diarrhea, abdominal pain, weight loss, and hypertension Dizziness, confusion, diaphoresis, and tachycardia Easy bruising, palpitations, cardiac dysrhythmias, and coma Question 5.5. Sulfonylureas may be added to a treatment regimen for type 2 diabetics when lifestyle modifications and metformin are insufficient to achieve This study source was downloaded by from CourseH on 04-23-2023 08:00:03 GMT -05:00 target glucose levels. Sulfonylureas have been moved to Step 2 therapy because they: (Points : 1) Increase endogenous insulin secretion Have a significant risk for hypoglycemia Address the insulin resistance found in type 2 diabetics Improve insulin binding to receptors Question 6.6. Treatment with insulin for type 1 diabetics: (Points : 1) Starts with a total daily dose of 0.2 to 0.4 units per kg of body weight Divides the total doses into three injections based on meal size Uses a total daily dose of insulin glargine given once daily with no other insulin required Is based on the level of blood glucose Question 7.7. The American Heart Association states that people with diabetes have a 2- to 4-fold increase in the risk of dying from cardiovascular disease. Treatments and targets that do not appear to decrease risk for micro- and macro-vascular complications include: (Points : 1) Glycemic targets between 7% and 7.5% Use of insulin in type 2 diabetics Control of hypertension and hyperlipidemia Stopping smoking Question 8.8. Drugs used to treat diabetic peripheral neuropathy include: (Points : 1) Metoclopramide Cholinergic agonists Cardioselective beta blockers Gabapentin Question 9.9. The goals of therapy when prescribing hormone replacement therapy (HRT) include reducing: (Points : 1) Cardiovascular risk Risk of stroke or other thromboembolic event Breast cancer Vasomotor symptoms Question 10.10. Inadequate vitamin D intake can contribute to the development of osteoporosis by: (Points : 1) Increasing calcitonin production Increasing calcium absorption from the intestine Altering calcium metabolism This study source was downloaded by from CourseH on 04-23-2023 08:00:03 GMT -05:00 Stimulating bone formation Question 11.11. The drug recommended as primary prevention of osteoporosis in men over age 70 years is: (Points : 1) Alendronate (Fosamax) Ibandronate (Boniva) Calcium carbonate Raloxifene (Evista) Question 12.12. In addition to methimazole, a symptomatic patient with hyperthyroidism may need a prescription for: (Points : 1) A calcium channel blocker A beta blocker Liothyronine An alpha blocker Question 13.13. When starting a patient on levothyroxine for hypothyroidism the patient will need follow-up measurement of thyroid function in: (Points : 1) 2 weeks 4 weeks 2 months 6 months Question 14.14. Treatment of a patient with hypothyroidism and cardiovascular disease consists of: (Points : 1) Levothyroxine Liothyronine Liotrix Methimazole Question 15.15. Men who use transdermal testosterone gel (AndroGel) should be advised to avoid: (Points : 1) Washing their hands after applying the gel Wearing occlusive clothing while using the gel Exposure to estrogens while using the gel